Secukinumab Treatment in Patients with Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study.

The multivariate analysis was then repeated with a second model that included only those variables that showed a significant or near-significant association ( P ≤ 0.25) with HiSCR response in univariate analysis (smoking status, Hurley stage, disease duration, biologic and adalimumab naivety).

also in 1,659 other papers